HOME >> BIOLOGY >> NEWS
Embryos exposed in 3-D

Utah and Texas researchers combined miniature medical CT scans with high-tech computer methods to produce detailed three-dimensional images of mouse embryos an efficient new method to test the safety of medicines and learn how mutant genes cause birth defects or cancer.

"Our method provides a fast, high-quality and inexpensive way to visually explore the 3-D internal structure of mouse embryos so scientists can more easily and quickly see the effects of a genetic defect or chemical damage," says Chris Johnson, a distinguished professor of computer science at the University of Utah.

A study reporting development of the new method known as "microCT-based virtual histology" was published recently in PLoS Genetics, an online journal of the Public Library of Science.

The study was led by Charles Keller, a pediatric cancer specialist who formerly worked as a postdoctoral fellow in the laboratory of University of Utah geneticist Mario Capecchi. Keller now is an assistant professor at the Children's Cancer Research Institute at the University of Texas Health Science Center in San Antonio.

University of Utah co-authors of the study are Johnson who directs the university's Scientific Computing and Imaging Institute Capecchi, medical student Mark S. Hansen and several members of Johnson's institute: computer science undergraduate Thomas Johnson III, research assistant Lindsey Healey and former associate director Greg M. Jones, who now is state science advisor to Utah Gov. Jon Huntsman Jr.

Scientists often use mouse embryos both to learn what genes do and to test the safety of new drugs and household chemicals. By disabling or "knocking out" a gene, researchers can see what goes wrong in the mouse embryo and thus learn the gene's normal function, or learn how a mutant gene can cause cancer. Mouse embryos also are sensitive to toxicity from chemicals, so new medicines and chemicals are tested on them to see if any defects develop
'"/>


4-May-2006


Page: 1 2 3

Related biology news :

1. Embryos tell story of Earths earliest animals
2. New data reveal pregnancies exposed to accutane despite risk management program
3. Lead-scrubbing drug may also improve muscle function in lead-exposed children
4. An infectious agent of deception, exposed through proteomics
5. Nearly a quarter of children are especially susceptible to respiratory illness if they are exposed to second-hand smoke
6. Finally, male water fleas exposed
7. UK College of Pharmacy to develop treatments for people exposed to dirty bomb
8. Penguin chicks exposed to human visitors experience spike in stress hormone
9. Workers exposed to Libby Vermiculite Ore have high rate of chest wall abnormalities
10. Mail-order drugs exposed to extreme heat become less effective

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2019)... ... December 04, 2019 , ... NDA Partners ... , a regulatory toxicology expert with more than 20 years of experience working ... , Dr. Todd has extensive experience with a variety of biologic modalities including ...
(Date:11/27/2019)... , ... November 25, 2019 , ... Though the forecast ... the more than 55 million travelers expected to hit the roads and the skies. ... worth it’s weight in truffle oil will offer a simple design, mouth-watering pictures of ...
(Date:11/27/2019)... ... November 27, 2019 , ... The ... with surface electromyography (sEMG) sensors that measure and display muscle activity in real ... muscles being targeted for treatment. Both patient and therapist can see when exercises ...
Breaking Biology News(10 mins):
(Date:11/9/2019)... BOSTON (PRWEB) , ... November ... ... provider of artificial intelligence (AI)-powered technology for use in pathology research, today ... in liver biopsy samples from patients enrolled in the phase 3 selonsertib ...
(Date:11/6/2019)... FRANCISCO (PRWEB) , ... November 06, 2019 , ... ... biopharma leaders through off-the-record collaboration and dialogue, today announces its East/West CEO ... Hotel in San Francisco. , Kicking off the week of ...
(Date:11/5/2019)... ... November 05, 2019 , ... Focal Healthcare ... Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information ... Bx 2.0 will give urologists across Europe the ability to perform targeted transrectal ...
(Date:11/2/2019)... ... , ... A clinical trial usually involves many different parties, ... investigators, supply chain managers, manufacturers, IRT, CRAs and so on. Lack of communication ... potentially leading to patient risk. , By having a single source of truth, ...
Breaking Biology Technology:
Cached News: